Back to Trials
NCT05743049Recruiting

Collection of Circulating Biomarkers in Pancreatic Cancer

Abramson Cancer Center at Penn Medicine

Start Date

2/27/2023

Completion Date

1/15/2028

Summary

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma * The subject must be a patient of the University of Pennsylvania * The subject must be able to provide informed consent * The subject must be 18 years of age or older Exclusion Criteria: . Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.

Interventions

OTHER

Obtaining blood for analysis of various circulating biomarkers

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Pancreas Cancer

Locations

Abramson Cancer Center at University of Pennsylvania

Philadelphia, Pennsylvania 19104

United States